Brief: Bioventus Enters Into Settlement Agreement To Preserve Maximum Optionality
28/02/2023 13:47
Feb 28 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS ENTERS INTO SETTLEMENT AGREEMENT TO PRESERVE
MAXIMUM
OPTIONALITY
* UP TO $350 MLN OF POTENTIAL LIABILITY REDUCTION AND A
RELEASE OF
FUTURE CLAIMS RELATED TO THE CARTIHEAL ACQUISITION
Source text for Eikon: ID:nGNX2J100B
Further company coverage: BVS.O
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks